Hepatitis E clinical trials
The registry lists 40 studies for Hepatitis E across more than 10 countries. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 23
- Recruiting
- 7
- Status unknown
- 6
- Terminated
- 2
- Not yet recruiting
- 2
Phase
- Phase 4
- 10
- Phase 2
- 6
- Phase 1
- 3
- Phase 3
- 2
Where
- China
- 11
- France
- 6
- Germany
- 2
- United States
- 2
- Switzerland
- 2
- India
- 2
Who runs them
Xiamen Innovax Biotech Co., Ltd (7) · Xiamen University (3) · International Vaccine Institute (2) · Norwegian Institute of Public Health (1) · All India Institute of Medical Sciences, New Delhi (1) · Ente Ospedaliero Cantonale, Bellinzona (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Maulana Azad Medical College (1)
Studies
Recruiting first, then most recently updated. Showing 40 of 40 — search for more.
- Study of AT-587 in Healthy SubjectsRecruitingNCT07728487Phase 11 country
- Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral HepatitisNot yet recruitingNCT07525401Not applicable
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT073589101 country
- Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in ChildrenRecruitingNCT06306196Phase 21 country
- Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne DiseasesNot yet recruitingNCT06859619Not applicable1 country
- Safety and Immunogenicity of Hecolin® in Healthy Pregnant WomenRecruitingNCT05808166Phase 21 country
- Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell DonorsRecruitingNCT06457438Not applicable1 country
- Exposure to Hepatitis E Virus in Occitania, FranceRecruitingNCT061373131 country
- Long-term Effectiveness of a Recombinant Hepatitis E VaccineRecruitingNCT059765941 country
- Seroprevalence of Hepatitis E in People With an Organ TransplantCompletedNCT021902531 country
- Prevalence of Hepatitis E During Follow-up Liver and Kidney Transplant Patients in Guadeloupe, French West IndiesCompletedNCT07729202Not applicable1 country
- Seroprevalence of Leptospirosis in Val Müstair, SwitzerlandCompletedNCT053004251 country
- Hepatitis E Virus Infection in Oncological PatientsCompletedNCT06631560Not applicable1 country
- Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and AboveCompletedNCT06564116Phase 41 country
- Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.CompletedNCT02759991Phase 41 country
- Immunogenicity and Safety of Co-immunization With Cecolin and HecolinStatus unknownNCT05415345Phase 41 country
- Safety Study of Hepatitis E Vaccine (HEV239)CompletedNCT03827395Phase 11 country
- Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral HepatitisTerminatedNCT00755950Phase 2/31 country
- Morbidity and Mortality of Hepatitis E Virus Infections in BelgiumCompletedNCT04670419
- Epidemiological Study of Hepatitis E Virus in Maintenance Hemodialysis PatientsCompletedNCT02645955
- Clinical Trial of Recombinant Hepatitis E VaccineCompletedNCT01014845Phase 31 country
- A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)CompletedNCT03365921Phase 41 country
- Seroprevalence Hepatitis E Infection in Healthy Blood DonorsCompletedNCT036012211 country
- A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )CompletedNCT02964910Phase 41 country
- A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.CompletedNCT00287469Phase 21 country
- Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.TerminatedNCT02558114Phase 41 country
- HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)CompletedNCT03282474Phase 21 country
- A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)CompletedNCT03168412Phase 41 country
- Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）CompletedNCT02189603Phase 41 country
- HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for LiverStatus unknownNCT03488589
- Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms.Status unknownNCT035240141 country
- Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)CompletedNCT028475071 country
- A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)CompletedNCT02584543Phase 41 country
- Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence StudyStatus unknownNCT02809885Not applicable1 country
- A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy AdultsCompletedNCT02603055Phase 11 country
- The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk FactorsStatus unknownNCT02419625Not applicable
- A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)CompletedNCT02417597Phase 41 country
- A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E VirusStatus unknownNCT01698723Phase 21 country
- Role of Cytokines in Hepatitis E Virus Infection During PregnancyCompletedNCT010623211 country
- Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus InfectionCompletedNCT01090232Not applicable1 country